NCT00107523View on ClinicalTrials.gov

Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2005

Conditions
Leukemia
Interventions
DRUG

cytarabine

DRUG

idarubicin

DRUG

pravastatin

Trial Locations (2)

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
lead

Fred Hutchinson Cancer Center

OTHER

NCT00107523 - Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter